*EMBARGOED All research presented at the 2019 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 28, 2019, at 8:00 am CDT.
P0012 Outcomes of Acute Necrotizing Pancreatitis and Associated Fluid Collections in Cannabis Users
Author Insight from C. Roberto Simons-Linares, MD, MSc, Cleveland Clinic
What’s new here and important for clinicians?
As cannabis continues to be legalized in the US, we expect that there will be an increase in cannabis user patients. In the settings of acute pancreatitis that is complicated with a pancreatic fluid collection, the impact of cannabis and the outcomes of cannabis users has not yet investigated. In our study, we found that cannabis users with acute necrotizing pancreatitis or fluid collection are more likely to have persistent systemic inflammatory response syndrome, acute kidney injury, and require ICU.
What do patients need to know?
Patients need to interpret with caution this study findings, as well as other research going on that, involves cannabis as a player; because cannabis impact and interplay factors have not yet been established and we need more investigations to determine the impact of cannabis in acute pancreatitis.
C. Roberto Simons-Linares, MD, MSc, Cleveland Clinic
robertosimons [at] outlook [dot] com
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi [dot] org or by phone at 301-263-9000.